Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS, HITRUST Team Up For Simulated Cyberattacks On Health Industry

This article was originally published in The Gray Sheet

Executive Summary

HHS and the information security firm have formed CyberRX, a program that will conduct simulated cyberattacks to test health care industry information systems and medical devices.

You may also be interested in...



FDA Cybersecurity Again In Spotlight As Hackers Breach CBER’s Database

A hacker gained access to information from about 14,000 users of the Center for Biologics Evaluation and Research’s submission systems during the government shutdown.

FDA Cybersecurity Efforts Emphasize Collaboration With Homeland Security Officials, Hospitals

CDRH’s emergency preparedness director spelled out the device center’s cybersecurity efforts during a recent webinar. The efforts go beyond guidance and regulations and include proactive steps to tackle the challenge, including weekly meetings with the Department of Homeland Security, she said.

FDA Proposal For Cybersecurity Info In Pre-market Submissions Generates Debate

Medical device firms and internet security groups disagree over whether an FDA guidance should recommend that companies document their cybersecurity measures in pre-market submissions.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT033354

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel